Low Risk of Hyperprogression with First-Line Chemoimmunotherapy for Advanced Non-Small Cell Lung Cancer: Pooled Analysis of 7 Clinical Trials

  1. Li, L.X.
  2. Cappuzzo, F.
  3. Matos, I.
  4. Socinski, M.A.
  5. Hopkins, A.M.
  6. Sorich, M.J.
Aldizkaria:
The oncologist

ISSN: 1549-490X

Argitalpen urtea: 2023

Alea: 28

Zenbakia: 4

Orrialdeak: e205-e211

Mota: Artikulua

DOI: 10.1093/ONCOLO/OYAD043 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus